Back to Search
Start Over
P1.15-09 First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study.
- Source :
- Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS123-S124, 2p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 17
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159037451
- Full Text :
- https://doi.org/10.1016/j.jtho.2022.07.205